Use of tocolytics: What is the benefit of gaining even more time?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue SUPPL. 3, 2006, Pages 78-80

  Jacquemyn, Y ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Atosiban; Beta agonists; Gestational age; Maintenance tocolysis; Preterm birth

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; MAGNESIUM SULFATE; NIFEDIPINE; OXYTOCIN ANTAGONIST; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; RITRODRINE; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

CHORIOAMNIONITIS; CLINICAL TRIAL; COMMUNITY HOSPITAL; COST EFFECTIVENESS ANALYSIS; DRUG USE; GENERAL PRACTITIONER; GESTATIONAL AGE; HEALTH SURVEY; HUMAN; LEUKOMALACIA; NEWBORN INTENSIVE CARE; PREGNANCY; PREMATURE LABOR; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR; TERTIARY HEALTH CARE; TOCOLYSIS; UNSPECIFIED SIDE EFFECT;

DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; TOCOLYTIC AGENTS;

EID: 33845566649     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01128.x     Document Type: Review

References (22)

1. Canadian Preterm Labour Investigations Group. Treatment of preterm labour with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308-12.
2. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005;2:CD001992.
3. Royal College of Obstetricians and Gynaecological Clinical Guideline No. 1 (B). Tocolytic Drugs for Women in Preterm Labour, 2002. [http://www.rcog.org. uk/resources/Public/pdf/Tocolytic_Drugs_No1(B).pdf]. Accessed 17 October 2006.
4. Thornton JG. Maintenance tocolysis. BJOG 2005;112(Suppl 1):118-25.
5. Anotayanonth S, Subhedar MV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004;4:CD004352.
6. Spinillo A, Capuzzo E, Stronati M, Ometto A, De Santolo A, Acciano S. Obstetrics Risk factors for periventricular leukomalacia among preterm infants. Br J Obstet Gynaecol 1998;105:865-71.
7. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyopathy. JAMA 2000;283:1183-8.
8. Nanda K, Cook LA, Gallo MF, Grimes DH. Teributaline pump maintenance therapy after threatened preterm labour for preventing preterm birth. Cochrane Database Syst Rev 2002;4:CD003933.
9. Macones GA, Berlin M, Berlin JA. Efficacy of oral beta-agonist maintenance therapy in preterm labour: a meta-analysis. Obstet Gynecol 1995;85:313-17.
10. Lam F, Isturan MB, Jacques D, Coleman SK, Stanzano GJ. Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labour. Manag Care 2003;12:39-46.
11. Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev 2000;2:CD000940.
12. Carr DD, Clarck AL, Kernek K, Spinato JA. Maintenance oral nifedipine for preterm labour, a randomised clinical trial. Am J Obstet Gynecol 1999;181:822-7.
13. Sayin NC, Varol FG, Balkanli-Kaplan P, Sayin M. Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labour. J Perinat Med 2004;32:220-4.
14. Shanan L, Sanchez-Ramos L, Kaunits A. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol 2005;106:173-9.
15. Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Kaltum WD, Millar L, et al. Maintenance treatment of preterm labour with the oxytocin antagonist atociban. Am J Obstet Gynecol 2000;182:1184-90.
16. Cook CM, Peek MJ. Survey of the management of preterm labour in Australia and New Zealand in 2002. Aust NZJ Obstet Gynaecol 2004;44:35-8.
17. Finström O, Olausson PO, Sedin G. The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Pediatr 1997;86:503-11.
18. Vanhaesebrouck P, Allegaert K, Bottu J, Debauche C, Devlieger H, Docx M, et al. The EPIBEL study: outcomes to discharge from hospital for extremely preterm infants in Belgium. Pediatrics 2004;114:663-75.
19. St John EB, Nelson KG, Clives SP, Bishnoi RR, Goldenberg RC. Cost of netonatal care according to gestational age at birth and survival states. Am J Obstet Gynecol 2000;182:170-5.
20. Bashiri A, Burstein E, Mazor M. Cerebral palsy and fetal inflammatory response syndrome - a review. J Perinat Med 2006;34:5-12.
21. Dammann O, Leviton A, Gappa M, Dammann CEL. Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long-term outcome. BJOG 2005;112(Suppl 1):4-9.
22. Pitzer M, Schmidt MM, Esser G, Laucht M. Child development after maternal tocolysis with beta sympathomimetic drugs. Child Psychiatry Hum Dev 2001;31:165-82.